Lisa Ferrara

President at OrthoKinetic Technologies, LLC

Lisa Ferrara

Lisa Ferrara

President at OrthoKinetic Technologies, LLC

Overview
Career Highlights

OrthoKinetic Technologies, LLC
OrhtoKinetic Testing Technologies, LLC

RelSci Relationships

384

Number of Boards

3

Relationships
RelSci Relationships are individuals Lisa Ferrara likely has professional access to. A relationship does not necessarily indicate a personal connection.

Attending Orthopedic Surgeon at Hospital for Special Surgery

Relationship likelihood: Strong

Executive Director, Western Office at The North Carolina Biotechnology Center

Relationship likelihood: Strong

Orthopedic Surgery, Sports Medicine at Hospital for Special Surgery

Relationship likelihood: Strong

Chief Executive Officer & Managing Director at HealthpointCapital LLC

Relationship likelihood: Strong

Director Emeritus at Hospital for Special Surgery

Relationship likelihood: Strong

Managing Director at HealthpointCapital LLC

Relationship likelihood: Strong

Co-Founder at Mobius Imaging LLC

Relationship likelihood: Strong

President & Chief Executive Officer at The North Carolina Biotechnology Center

Relationship likelihood: Strong

Managing Director & Chief Financial Officer at HealthpointCapital LLC

Relationship likelihood: Strong

Member Emeritus, Scientific Board of Advisors at HealthpointCapital LLC

Relationship likelihood: Strong

Paths to Lisa Ferrara
Potential Connections via
Relationship Science
You
Lisa Ferrara
President at OrthoKinetic Technologies, LLC
Career History
President
Current
Director, Spine Research Laboratory, Department of Neurosurgery & Orthopedics
Prior

Part of The Cleveland Clinic Foundation, Cleveland Clinic Hospital is a company headquartered in Weston, FL, that operates general and surgical hospital. On 02 Oct 06 The Cleveland Clinic Foundation acquired Cleveland Clinic Hospital from Tenet Healthcare Corp.

Boards & Committees
Member, Scientific Board of Advisors
Current

HealthpointCapital is a value-driven, research-based private equity firm that focuses exclusively on investments in the healthcare sector related to the musculoskeletal sector, with emphasis on the orthopedics and dental clinical areas. The firm looks for companies that are developing changes to current products that don't expand the continuum, but do improve handling characteristics or the performance aspects of an implant or instrument.HealthpointCapital also seeks technologies or innovations that expand a therapy that is already being utilized in the continuum of care. Companies may expand the use of a therapy to older and/or younger patients or offer refinements that divide an existing therapy into more specialized elements. The firm is also interested in technologies that create therapies to treat previously untreatable orthopedic diseases or conditions, adding a new segment to the existing continuum of care. Finally, HealthpointCapital seeks to invest in new, disruptive technologies that replace or make existing therapies obsolete.

Member, Advisory Committee for Biotechnology
Current

The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC.

Member, Medical Device Advisory Committee
Prior

The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), and veterinary products. The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction. The FDA is led by the Commissioner of Food and Drugs, appointed by the President with the advice and consent of the Senate. The Commissioner reports to the Secretary of Health and Human Services. The 21st and current Commissioner is Dr. Margaret A. Hamburg. She has served as Commissioner since May 2009. The FDA has its headquarters in unincorporated White Oak, Maryland. The agency also has 223 field offices and 13 laboratories located throughout the 50 states, the United States Virgin Islands, and Puerto Rico. In 2008, the FDA started opening offices in foreign countries, including China, India, Costa Rica, Chile, Belgium, and the United Kingdom. In June 1906, President Theodore Roosevelt signed into law the Food and Drug Act, also known as the "Wiley Act" after its chief advocate Dr. Harvey Washington Wiley who riveted the country's and eventually congress's attention with public hygiene demonstrations. This act was the basis for the modern USFDA, being originally given the name of the Food, Drug, and Insecticide organization. The name eventually was shortened to the Food and Drug Administration (FDA) a few years later.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lisa Ferrara. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lisa Ferrara's profile does not indicate a business or promotional relationship of any kind between RelSci and Lisa Ferrara.